Recombinant Hepatitis C Virus nucleocapsid protein (ab43027)

製品の概要

  • 製品名Recombinant Hepatitis C Virus nucleocapsid protein
  • タンパク質長Full length protein

製品の詳細

  • 由来Recombinant
  • 由来Escherichia coli
  • アミノ酸配列
    • 配列の追加情報The protein contains the HCV nucleocapsid immunodominant regions.

特性

Our Abpromise guarantee covers the use of ab43027 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • 生理活性Immunoreactive with sera of HCV infected individuals.
  • アプリケーション

    ELISA

    Western blot

  • 精製度> 95 % SDS-PAGE.
    Sepharose derived purification.
  • 製品の状態Liquid
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Preservative: None
    Constituents: 50mM Tris, 0.5mM EDTA, pH 8

関連情報

  • 別名
    • HCV
    • HCV nucleocapsid protein
    • Hepatitis C virus
  • 関連性The Hepatitis C virus (HCV) is a small (50 nm in size), enveloped, single-stranded, positive sense RNA virus in the family Flaviviridae. HCV, which is principally transmitted by blood, infects about 3% of the world's population. HCV infection causes acute hepatitis. Circulating HCV particles bind to receptors on the surfaces of hepatocytes and subsequently enter the cells.

Recombinant Hepatitis C Virus nucleocapsid protein (ab43027) 使用論文

ab43027 has not yet been referenced specifically in any publications.

Product Wall

Thank you for your enquiry. 1) Molecular weight is 39918.16 Dalton and the pI value is 9.73 2) The full length sequence cannot be provided but it does include 1-90 aa sequence.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"